Trials / Completed
CompletedNCT03608826
Relationship Between LINQ™ Subcutaneous Impedance and Right-sided Hemodynamic Measurements
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the ReLINQuish study is to characterize the relationship between subcutaneous impedance and hemodynamic measurements in patients with heart failure. Additionally, the relationship between changes in subcutaneous impedance and other physiologic parameters during acute decompensated HF events will be characterized.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Investigational LINQ™ HF RAMware | The Reveal LINQ™ device and the 2090 programmer are market-released, but once the investigational LINQ™ HF RAMware is downloaded into the devices, they are considered investigational. |
Timeline
- Start date
- 2018-07-13
- Primary completion
- 2021-05-07
- Completion
- 2021-05-07
- First posted
- 2018-08-01
- Last updated
- 2022-12-23
- Results posted
- 2022-12-23
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03608826. Inclusion in this directory is not an endorsement.